NCT00093301View on ClinicalTrials.gov

Levosimendan Versus Dobutamine in Shock Patients

PHASE2/PHASE3UnknownINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

October 31, 2004

Study Completion Date

April 30, 2006

Conditions

Cardiogenic ShockSeptic Shock

Interventions

DRUG

Levosimendan

DRUG

Dobutamine

Trial Locations (1)

2750

RECRUITING

Intensive Care Unit, Nepean Hospital, Penrith

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Abbott

INDUSTRY

lead

Wentworth Area Health Services

OTHER